ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours: Houston Saturday, March 8, 2025, 18:00 Hr ...
Macbecin II was identified as a compound that upregulates MHC-I expression, enhancing immune-mediated cancer cell killing. In ...
7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new ... Breakthrough in Childhood Brain Cancer ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
Mar. 12, 2025 — Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive ...
Poland: A recent simulation study published in Scientific Reports revealed that individuals with asthma and chronic ...
1Houston Methodist Neal Cancer Center, Houston, TX.
4 天
News-Medical.Net on MSNGLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patientsResearchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...
17 小时
News-Medical.Net on MSNStudy shows how autism-linked picky eating causes serious vitamin deficienciesChildren with autism spectrum disorder (ASD) face a high risk of multiple micronutrient deficiencies, especially vitamins A, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果